Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 1
2009 1
2010 2
2011 3
2012 1
2013 1
2014 2
2016 3
2018 1
2019 1
2020 3
2021 3
2022 3
2023 5
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Results by year

Filters applied: . Clear all
Page 1
Patient-specific signaling signatures predict optimal therapeutic combinations for triple negative breast cancer.
Alkhatib H, Conage-Pough J, Roy Chowdhury S, Shian D, Zaid D, Rubinstein AM, Sonnenblick A, Peretz-Yablonsky T, Granit A, Carmon E, Kohale IN, Boughey JC, Goetz MP, Wang L, White FM, Kravchenko-Balasha N. Alkhatib H, et al. Among authors: kravchenko balasha n. Mol Cancer. 2024 Jan 16;23(1):17. doi: 10.1186/s12943-023-01921-9. Mol Cancer. 2024. PMID: 38229082 Free PMC article.
Paclitaxel Delivery to the Brain for Glioblastoma Treatment.
AbdEl-Haq M, Kumar A, Ait Mohand FE, Kravchenko-Balasha N, Rottenberg Y, Domb AJ. AbdEl-Haq M, et al. Among authors: kravchenko balasha n. Int J Mol Sci. 2023 Jul 21;24(14):11722. doi: 10.3390/ijms241411722. Int J Mol Sci. 2023. PMID: 37511480 Free PMC article.
Molecular changes in breast cancer induced by radiation therapy.
Sheva K, Chowdhury SR, Kravchenko-Balasha N, Meirovitz A. Sheva K, et al. Among authors: kravchenko balasha n. Int J Radiat Oncol Biol Phys. 2024 Mar 18:S0360-3016(24)00435-8. doi: 10.1016/j.ijrobp.2024.03.019. Online ahead of print. Int J Radiat Oncol Biol Phys. 2024. PMID: 38508467 Review.
Heparanase: a potential marker of worse prognosis in estrogen receptor-positive breast cancer.
Zahavi T, Salmon-Divon M, Salgado R, Elkin M, Hermano E, Rubinstein AM, Francis PA, Di Leo A, Viale G, de Azambuja E, Ameye L, Sotiriou C, Salmon A, Kravchenko-Balasha N, Sonnenblick A. Zahavi T, et al. Among authors: kravchenko balasha n. NPJ Breast Cancer. 2021 May 28;7(1):67. doi: 10.1038/s41523-021-00277-x. NPJ Breast Cancer. 2021. PMID: 34050190 Free PMC article.
33 results